Lindenwold Advisors’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$337K Buy
11,895
+115
+1% +$3.06K 0.16% 82
2025
Q2
$259K Sell
11,780
-56
-0.5% -$1.22K 0.13% 92
2025
Q1
$276K Sell
11,836
-229
-2% -$5.86K 0.15% 86
2024
Q4
$347K Sell
12,065
-474
-4% -$14.2K 0.19% 82
2024
Q3
$372K Buy
12,539
+347
+3% +$10.8K 0.19% 80
2024
Q2
$411K Sell
12,192
-332
-3% -$11.5K 0.22% 75
2024
Q1
$452K Buy
12,524
+106
+0.9% +$3.67K 0.24% 70
2023
Q4
$406K Sell
12,418
-136
-1% -$4.2K 0.23% 75
2023
Q3
$409K Buy
12,554
+43
+0.3% +$1.38K 0.25% 63
2023
Q2
$366K Sell
12,511
-4,078
-25% -$112K 0.22% 75
2023
Q1
$465K Buy
16,589
+224
+1% +$6.31K 0.29% 71
2022
Q4
$446K Sell
16,365
-1,372
-8% -$36.6K 0.3% 75
2022
Q3
$423K Buy
17,737
+167
+1% +$4.58K 0.31% 74
2022
Q2
$491K Buy
17,570
+168
+1% +$4.89K 0.35% 68
2022
Q1
$508K Buy
17,402
+1,040
+6% +$32.3K 0.31% 74
2021
Q4
$570K Buy
+16,362
New +$581K 0.33% 71

Other funds holding GNTX

Lindenwold Advisors's GNTX Position: Q3 2025 in Review

Lindenwold Advisors increased its Gentex (GNTX) stake by 0.98% in Q3 2025, buying an estimated $3.06K and bringing the position to 11,895 shares worth $337K. The position accounts for 0.16% of the portfolio, ranked #82.

Lindenwold Advisors first reported a position in GNTX in Q4 2021 and has held it in 16 quarters since. The position peaked at $570K in Q4 2021. 510 funds tracked by Wall St. Rank hold GNTX as of Q3 2025.

  • Lindenwold Advisors held 11,895 shares of Gentex worth $337K as of Q3 2025.
  • Lindenwold Advisors bought 115 Gentex shares in Q3 2025, an estimated $3.06K.
  • Gentex made up 0.16% of Lindenwold Advisors's portfolio in Q3 2025, its #82 holding.
  • Lindenwold Advisors first reported a position in Gentex in Q4 2021 and has held it in 16 quarters since.
  • Lindenwold Advisors's Gentex position peaked at $570K in Q4 2021.
  • 510 funds tracked by Wall St. Rank held Gentex as of Q3 2025.

Based on Lindenwold Advisors's 13F filing for Q3 2025, filed 16 Dec 2025.